Discover 1 curated intelligence briefings related to this specific topic.
As whole-genome sequencing becomes a clinical default, the industry is colliding with a massive volume of Variants of Uncertain Significance (VUS). From under-represented Indian cohorts to the emergence of Optical Genome Mapping, the fight to turn genetic noise into actionable data is intensifying.
